TQA3605

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TQA3605, covering 2024-11-14 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection [Phase 2]

See pricing